EVO•The RAG Foundation said it could sell its entire stake in Evonik, where it currently holds around 43%. It has previously said it intends to reduce its holding to a blocking minority of 25.1%.
The foundation said its statutes allow a complete disposal of Evonik. With approval from its board of trustees, it could sell additional shares up to and including a full divestment.
RAG holds around 43% of the German chemicals manufacturer and has previously stated its intention to cut its stake to 25.1%, a blocking minority. The board of trustees is dominated by politicians and trade union representatives.
